16621

    212107

    VAISHALI

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    VAISHALI PHARMA LIMITED Share Price Today

    VAISHALI PHARMA LIMITED is currently trading at ₹7.82, down by ₹0.05 from the previous close. The stock touched an intraday high of ₹8.18 and a low of ₹7.72 during the latest trading session. Over the past one year, VAISHALI PHARMA LIMITED has delivered a loss of 38.86%, while the stock has gained 10.05% in the last one month.

    VAISHALI PHARMA LIMITED performance

    Today’s low Today’s high
    ₹ 7.72 ₹ 8.18
    ₹ 7.84
    52 week low 52 week high
    ₹ 4.75 ₹ 13.59
    ₹ 7.84
    Open Price ₹ 7.88
    Prev. Close ₹ 7.88
    Volume (Shares) 23489.00
    Total traded value ₹ 1.84
    Upper Circuit ₹ 8.27
    Lower Circuit ₹ 7.49
    info

    Investment Returns

    Over 1 Month 10.05% Over 3 Months 20.30% Over 6 Months -7.51% Over 1 Year -38.86%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    VAISHALI PHARMA LIMITED fundamentals


    • Market cap (Cr) 102.30
    • P/E Ratio (TTM) 25.29
    • Beta 1.18
    • Book Value / share 5.28
    • Return on equity 1.52%
    • EPS (TTM) 0.31
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 0.27
    info icon alternate text
    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) [-]
    info icon alternate text

    VAISHALI PHARMA LIMITED Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 26.93
    Operating Expense 28.00
    Net Profit 0.27
    Net Profit Margin (%) 1.00
    Earnings Per Share (EPS) 0.02
    EBITDA 1.05
    Effective Tax Rate (%) -50.00
    Particulars DEC 2025 (Values in Cr)
    Revenue 24.65
    Operating Expense 23.73
    Net Profit 1.30
    Net Profit Margin (%) 5.27
    Earnings Per Share (EPS) 0.10
    EBITDA 2.46
    Effective Tax Rate (%) 28.02
    Particulars SEP 2025 (Values in Cr)
    Revenue 33.45
    Operating Expense 32.62
    Net Profit 1.18
    Net Profit Margin (%) 3.52
    Earnings Per Share (EPS) -0.49
    EBITDA 2.23
    Effective Tax Rate (%) 28.31
    Particulars JUN 2025 (Values in Cr)
    Revenue 23.75
    Operating Expense 22.84
    Net Profit 1.28
    Net Profit Margin (%) 5.38
    Earnings Per Share (EPS) 0.10
    EBITDA 2.21
    Effective Tax Rate (%) 26.43
    Particulars MAR 2025 (Values in Cr)
    Revenue 32.25
    Operating Expense 38.84
    Net Profit -4.29
    Net Profit Margin (%) -13.30
    Earnings Per Share (EPS) -0.33
    EBITDA -5.03
    Effective Tax Rate (%) 23.39
    Particulars MAR 2026 (Values in Cr)
    Revenue 108.77
    Operating Expense 107.22
    Net Profit 4.03
    Net Profit Margin (%) 3.70
    Earnings Per Share (EPS) 0.31
    EBITDA 7.94
    Effective Tax Rate (%) 25.23
    Particulars MAR 2025 (Values in Cr)
    Revenue 99.03
    Operating Expense 101.00
    Net Profit 0.82
    Net Profit Margin (%) 0.82
    Earnings Per Share (EPS) 0.06
    EBITDA 3.30
    Effective Tax Rate (%) 33.33
    Particulars MAR 2024 (Values in Cr)
    Revenue 86.28
    Operating Expense 87.39
    Net Profit 0.72
    Net Profit Margin (%) 0.83
    Earnings Per Share (EPS) 0.67
    EBITDA 3.17
    Effective Tax Rate (%) 22.58
    Particulars MAR 2023 (Values in Cr)
    Revenue 69.66
    Operating Expense 63.05
    Net Profit 6.60
    Net Profit Margin (%) 9.47
    Earnings Per Share (EPS) 6.26
    EBITDA 11.36
    Effective Tax Rate (%) 25.31
    Particulars MAR 2022 (Values in Cr)
    Revenue 75.82
    Operating Expense 71.88
    Net Profit 4.02
    Net Profit Margin (%) 5.30
    Earnings Per Share (EPS) 3.82
    EBITDA 8.65
    Effective Tax Rate (%) 29.66
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 4.98
    ROE % 1.52
    ROCE % 4.92
    Total Debt to Total Equity 0.24
    EBITDA Margin 3.82
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 33.41
    ROE % 1.73
    ROCE % 5.71
    Total Debt to Total Equity 0.34
    EBITDA Margin 4.29
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 38.43
    ROE % 19.73
    ROCE % 21.59
    Total Debt to Total Equity 0.53
    EBITDA Margin 16.67
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 24.99
    ROE % 16.48
    ROCE % 18.70
    Total Debt to Total Equity 0.79
    EBITDA Margin 11.43
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 21.26
    ROE % 4.79
    ROCE % 10.23
    Total Debt to Total Equity 0.80
    EBITDA Margin 8.29
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 1.84
    Total Assets 109.84
    Total Liabilities 109.84
    Total Equity 64.91
    Share Outstanding 13
    Price to Book Ratio 2.53
    Return on Assets (%) 0.74
    Return on Capital (%) 1.07
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 1.57
    Total Assets 79.95
    Total Liabilities 79.95
    Total Equity 42.83
    Share Outstanding 1
    Price to Book Ratio 3.50
    Return on Assets (%) 0.89
    Return on Capital (%) 1.3
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 0.98
    Total Assets 78.89
    Total Liabilities 78.89
    Total Equity 40.53
    Share Outstanding 1
    Price to Book Ratio 3.80
    Return on Assets (%) 8.36
    Return on Capital (%) 12.18
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 1.35
    Total Assets 81.62
    Total Liabilities 81.62
    Total Equity 26.35
    Share Outstanding 1
    Price to Book Ratio 2.65
    Return on Assets (%) 4.92
    Return on Capital (%) 8.54
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 0.46
    Total Assets 86.12
    Total Liabilities 86.12
    Total Equity 22.41
    Share Outstanding 1
    Price to Book Ratio 1.53
    Return on Assets (%) 1.21
    Return on Capital (%) 2.62
    Particulars MAR 2025 (Values in Cr)
    Net Income 1.22
    Cash from Operations -17.68
    Cash from Investing -0.18
    Cash from Financing 18.49
    Net change in Cash 0.26
    Free Cash Flow -17.38
    Particulars MAR 2024 (Values in Cr)
    Net Income 0.92
    Cash from Operations 3.08
    Cash from Investing 1.20
    Cash from Financing -1.41
    Net change in Cash 0.59
    Free Cash Flow 3.19
    Particulars MAR 2023 (Values in Cr)
    Net Income 8.84
    Cash from Operations 2.64
    Cash from Investing 0.28
    Cash from Financing -1.73
    Net change in Cash -0.37
    Free Cash Flow 2.94
    Particulars MAR 2022 (Values in Cr)
    Net Income 5.72
    Cash from Operations 2.14
    Cash from Investing -0.84
    Cash from Financing 0.41
    Net change in Cash 0.88
    Free Cash Flow 3.01
    Particulars MAR 2021 (Values in Cr)
    Net Income 1.40
    Cash from Operations 2.07
    Cash from Investing -0.11
    Cash from Financing -1.81
    Net change in Cash 0.08
    Free Cash Flow 2.20
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.09 12.90 1.50 238.25 23.12 38.85
    BLISS GVS PHARMA LTD 503.85 40.50 4.47 5343.64 118.35 552.90
    CIPLA LTD 1429.45 30.34 3.35 115477.45 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 459.95 20.29 3.32 1353.68 256.40 480.00
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 31.09 21.74 4.00 238.25 23.12 38.85
    AMRUTANJAN HEALTH CARE LTD. 534.05 23.94 4.17 1543.97 490.00 789.95
    ASTRAZENECA PHARMA IND LT 8092.00 105.68 23.17 20230.00 7630.00 9850.00
    BLISS GVS PHARMA LTD 503.85 54.47 4.62 5343.64 118.35 552.90

    VAISHALI PHARMA LIMITED shareholding pattern

    Holding
    69.45%
    30.54%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    VAISHALI PHARMA LIMITED Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    7.84 -0.50 redarrow
    red-green-graph indicator
    3 Bearish
    13 Bullish
    • 5 Days 7.80
    • 26 Days 7.50
    • 10 Days 7.70
    • 50 Days 7.40
    • 12 Days 7.70
    • 100 Days 7.50
    • 20 Days 7.60
    • 200 Days 8.50
    7.83 PIVOT
    First Support 7.57 First Resistance 8.15 Second Support 7.25 Second Resistance 8.41 Third Support 6.99 Third Resistance 8.73
    RSI 60.59 ADX 31.35 MACD 0.15 Williams % R -29.09 Commodity Channel Index (CCI) 120.82
    Date 2024-11-26 Week 122953.00 Same Day 136793.00 Month 158529.00
    1 Year 1.19 3 Year 0.86
    Over 1 Month
    10.05% down
    Over 1 Year
    -38.86% down
    Over 3 Months
    20.30% down
    Over 3 Years
    -14.25% down
    Over 6 Months
    -7.51% down
    Over 5 Years
    13.35% down

    VAISHALI PHARMA LIMITED Corporate Actions

    Ex-Date Ex-Bonus Ratio
    15 Oct 2024 15 Oct 2024 1:1
    18 Oct 2019 17 Oct 2019 3:5
    Ex-Date Old FV NEW FV Record Date
    15 Oct 2024 10.0 2.0 15 Oct 2024
    Ex-Date Ex-Bonus Ratio
    15 Oct 2024 15 Oct 2024 1:1
    18 Oct 2019 17 Oct 2019 3:5
    Ex-Date Old FV NEW FV Record Date
    15 Oct 2024 10.0 2.0 15 Oct 2024

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Vaishali Pharma Ltd?

    Answer Field

    Vaishali Pharma Ltd share price is for NSE ₹ 7.82 & for BSE ₹ 0.00 as on Jul 17 2026 03:29 PM.

    What is the Market Cap of Vaishali Pharma Ltd Share?

    Answer Field

    The market cap of Vaishali Pharma Ltd for NSE ₹ 102.30 & for BSE ₹ 0.00 as on Jul 17 2026 03:29 PM.

    What is the 52 Week High and Low of Vaishali Pharma Ltd?

    Answer Field

    The 52 Week High and Low of Vaishali Pharma Ltd for NSE is ₹ 13.59 and ₹ 4.75 and for BSE is ₹ 0.00 and ₹ 0.00.

    What is 1 year return for Vaishali Pharma Ltd?

    Answer Field

    The 1 year returns on the stock has been -39.64%.

    What is the P/E Ratio of Vaishali Pharma Ltd Share?

    Answer Field

    As on Jul 17 2026 03:29 PM the price-to-earnings (PE) ratio for Vaishali Pharma Ltd share is 25.29.

    What is the PB ratio of Vaishali Pharma Ltd Share?

    Answer Field

    As on Jul 17 2026 03:29 PM, the price-to-book (PB) ratio for Vaishali Pharma Ltd share is 5.28.

    How to Buy Vaishali Pharma Ltd Share?

    Answer Field

    You can trade in Vaishali Pharma Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Vaishali Pharma Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Vaishali Pharma Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Vaishali Pharma Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |